Today at the 2013 Radiological Society of North America (RSNA) annual meeting, GE Healthcare, a unit of General Electric Company (NYSE: GE), unveiled four software breakthroughs to deliver improved clinical capabilities, productivity and diagnostic confidence for clinicians.
Up-to-date, reliable and accurate software is critical to quality care for the patient and usability for the clinicaian. GE Healthcare recently announced a $2 billion investment in software development that is focused on maximizing asset performance, improving hospital operations management, improving clinical effectiveness and optimizing care across entire populations. And today, GE Healthcare’s Xeleris 3.1, DV24.0, VolumeRAD*, Enterprise Imaging Solutions and iCenter further demonstrated this commitment.
Xeleris 3.1 delivers automation and personalization for clinicians
In Nuclear Medicine, one of the greatest challenges clinicians face is access to the advanced and unique applications required to harness the power of Nuclear Medicine examinations. The latest release of GE Healthcare’s Xeleris software enables automation, personalization and access to these advanced applications. Nuclear Medicine clinicians will gain access to specific image results where and when they are needed. With its open interface architecture, Xeleris applications can now be launched through an integrated unified desktop from the Universal Viewer, as well as using the generic Application Programming Interface with other PACS vendors, providing radiologists and Nuclear Medicine physicians with tools previously only available on the Xeleris workstation, for enhanced access and productivity.The Xeleris workstation includes DaTQUANT*, which enables visual evaluation and quantification of 123I Ioflupane images. This application provides tools to analyze dopaminergic neuron terminal binding and differences between multiple scans and may provide adjunct information to physicians assessing patients for Parkinson’s disease. It also provides an exclusive AdreView™ planar application for automated heart to mediastinum ratio generation for Iobenguane I-123 images and the Dosimetry Toolkit for a quantitative SPECT and Planar calculation of the Radioisotope Therapy planning value.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts